Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (564)	4/1/1999 4:15:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4974

Here is today's PR which caught my attention. STI and JDF Collaborating to Advance Cellular Implant Treatment for Diabetes biz.yahoo.com STI's initial development of the therapy has shown long-term survival of Sertoli cell/islet grafts in both lower and higher animals. The new STI-JDF collaboration will develop Sertoli cell/islet allografts-using tissue from the same species-to cure diabetes in animal and preclinical models. part of the reason I bought ctii was just this sort of thing... fyi...Neocrin and Neurocrine also come up on a recap query using just "islet".